Cargando…
A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage
Asymptomatic carriage of Salmonella Typhi continues to facilitate the transmission of typhoid fever, resulting in 14 million new infections and 136,000 fatalities each year. Asymptomatic chronic carriage of S. Typhi is facilitated by the formation of biofilms on gallstones that protect the bacteria...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793255/ https://www.ncbi.nlm.nih.gov/pubmed/33370414 http://dx.doi.org/10.1371/journal.ppat.1009192 |
_version_ | 1783633947928821760 |
---|---|
author | Sandala, Jenna L. Eichar, Bradley W. Kuo, Laura G. Hahn, Mark M. Basak, Akash K. Huggins, William M. Woolard, Katherine Melander, Christian Gunn, John S. |
author_facet | Sandala, Jenna L. Eichar, Bradley W. Kuo, Laura G. Hahn, Mark M. Basak, Akash K. Huggins, William M. Woolard, Katherine Melander, Christian Gunn, John S. |
author_sort | Sandala, Jenna L. |
collection | PubMed |
description | Asymptomatic carriage of Salmonella Typhi continues to facilitate the transmission of typhoid fever, resulting in 14 million new infections and 136,000 fatalities each year. Asymptomatic chronic carriage of S. Typhi is facilitated by the formation of biofilms on gallstones that protect the bacteria from environmental insults and immune system clearance. Here, we identified two unique small molecules capable of both inhibiting Salmonella biofilm growth and disrupting pre-formed biofilm structures without affecting bacterial viability. In a mouse model of chronic gallbladder Salmonella carriage, treatment with either compound reduced bacterial burden in the gallbladder by 1–2 logs resulting in bacterial dissemination to peripheral organs that was associated with increased mortality. Co-administration of either compound with ciprofloxacin not only enhanced compound efficacy in the gallbladder by a further 1–1.5 logs for a total of 3–4.5 log reduction, but also prevented bacterial dissemination to peripheral organs. These data suggest a dual-therapy approach targeting both biofilm and planktonic populations can be further developed as a safe and efficient treatment of biofilm-mediated chronic S. Typhi infections. |
format | Online Article Text |
id | pubmed-7793255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-77932552021-01-27 A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage Sandala, Jenna L. Eichar, Bradley W. Kuo, Laura G. Hahn, Mark M. Basak, Akash K. Huggins, William M. Woolard, Katherine Melander, Christian Gunn, John S. PLoS Pathog Research Article Asymptomatic carriage of Salmonella Typhi continues to facilitate the transmission of typhoid fever, resulting in 14 million new infections and 136,000 fatalities each year. Asymptomatic chronic carriage of S. Typhi is facilitated by the formation of biofilms on gallstones that protect the bacteria from environmental insults and immune system clearance. Here, we identified two unique small molecules capable of both inhibiting Salmonella biofilm growth and disrupting pre-formed biofilm structures without affecting bacterial viability. In a mouse model of chronic gallbladder Salmonella carriage, treatment with either compound reduced bacterial burden in the gallbladder by 1–2 logs resulting in bacterial dissemination to peripheral organs that was associated with increased mortality. Co-administration of either compound with ciprofloxacin not only enhanced compound efficacy in the gallbladder by a further 1–1.5 logs for a total of 3–4.5 log reduction, but also prevented bacterial dissemination to peripheral organs. These data suggest a dual-therapy approach targeting both biofilm and planktonic populations can be further developed as a safe and efficient treatment of biofilm-mediated chronic S. Typhi infections. Public Library of Science 2020-12-28 /pmc/articles/PMC7793255/ /pubmed/33370414 http://dx.doi.org/10.1371/journal.ppat.1009192 Text en © 2020 Sandala et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Sandala, Jenna L. Eichar, Bradley W. Kuo, Laura G. Hahn, Mark M. Basak, Akash K. Huggins, William M. Woolard, Katherine Melander, Christian Gunn, John S. A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage |
title | A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage |
title_full | A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage |
title_fullStr | A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage |
title_full_unstemmed | A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage |
title_short | A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage |
title_sort | dual-therapy approach for the treatment of biofilm-mediated salmonella gallbladder carriage |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793255/ https://www.ncbi.nlm.nih.gov/pubmed/33370414 http://dx.doi.org/10.1371/journal.ppat.1009192 |
work_keys_str_mv | AT sandalajennal adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT eicharbradleyw adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT kuolaurag adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT hahnmarkm adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT basakakashk adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT hugginswilliamm adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT woolardkatherine adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT melanderchristian adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT gunnjohns adualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT sandalajennal dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT eicharbradleyw dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT kuolaurag dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT hahnmarkm dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT basakakashk dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT hugginswilliamm dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT woolardkatherine dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT melanderchristian dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage AT gunnjohns dualtherapyapproachforthetreatmentofbiofilmmediatedsalmonellagallbladdercarriage |